J 2026

Clinical Characteristics, Management and Outcomes of Nonintensive Care Unit Candidemia: Subanalysis of the ECMM Candida III Multinational European Observational Cohort Study

WOLFGRUBER, Stella; Carolina GARCIA-VIDAL; Sarah SEDIK; Jon SALMANTON-GARCIA; Sevtap ARIKAN-AKDAGLI et al.

Základní údaje

Originální název

Clinical Characteristics, Management and Outcomes of Nonintensive Care Unit Candidemia: Subanalysis of the ECMM Candida III Multinational European Observational Cohort Study

Autoři

WOLFGRUBER, Stella; Carolina GARCIA-VIDAL; Sarah SEDIK; Jon SALMANTON-GARCIA; Sevtap ARIKAN-AKDAGLI; Jean-Pierre GANGNEUX; Riina RAUTEMAA-RICHARDSON; Valentina ARSIC-ARSENIJEVIC; Sonia MARTIN-PEREZ; Julio DAVILA-VALLS; Nurettin ERBEN; Emin Halis AKALIN; Lubos DRGONA; Cornelia LASS-FLORL; Julio GARCIA-RODRIGUEZ; Tihana BICANIC; Helena HAMMARSTROM; Petr HAMAL; Jorg STEINMANN; Eelco F J MEIJER; Nina KHANNA; Guillaume DESOUBEAUX; Thomas LONGVAL; Uluhan SILI; Janina TRAUTH; Matteo BASSETTI; P Lewis WHITE; Avinash AUJAYEB; Tadeja MATOS; Deniz AKYOL; Francois DANION; Katrien LAGROU; Benedict ROGERS; Maite RUIZ; Alena SIVÁKOVÁ; Malgorzata MIKULSKA; Michael SAMARKOS; Ola BLENNOW; Deborah E A LOCKHART; Blandine DENIS; Birgit WILLINGER; Van Dijk KARIN; Ulrike SCHARMANN; Anna L GOODMAN; Van Praet JENS; Manjusha NARAYANAN; Cristina TOSCANO; Laura LOUGHLIN; De Jonge Nick ALEXANDER; Alba RUIZ-GAITAN; Fanny LANTERNIER; Juergen PRATTES; Emmanuel ROILIDES; Alida Fe TALENTO; Aleksandra BARAC; Matthias EGGER; Maiken Cavling ARENDRUP; Philipp KOEHLER; Oliver A CORNELY a Martin HOENIGL

Vydání

OPEN FORUM INFECTIOUS DISEASES, CARY, OXFORD UNIV PRESS INC, 2026, 2328-8957

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30303 Infectious Diseases

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 3.800 v roce 2024

Označené pro přenos do RIV

Ano

Organizační jednotka

Lékařská fakulta

EID Scopus

Klíčová slova anglicky

candidemia; disease outcome; invasive fungal infections; non-ICU

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 5. 5. 2026 12:39, Mgr. Tereza Miškechová

Anotace

V originále

The European Confederation of Medical Mycology Candida III was a pan-European, multicenter observational study of adult patients with blood culture–proven candidemia. Among a total of 632 patients with candidemia across 64 institutions in 20 European countries, a subanalysis of 396 (63%) cases occurring outside the intensive care unit (ICU) was conducted. Compared with ICU patients, non-ICU patients had a higher comorbidity burden (median Charlson comorbidity index [CCI] 6 vs 5 in ICU patients, P = .006). Hematologic and oncologic malignancies were more frequent among non-ICU cases (45.5% vs 28.4%, P < .001), whereas both chronic kidney and cardiovascular disease were more prevalent in ICU patients (P < .001). Non-ICU patients had significantly lower mortality in Kaplan–Meier survival analysis (P > .001). Postsurgical non-ICU patients (n = 45) had the highest survival rate (73.3%, P = .003) and the longest hospital stay, even after excluding all cases with a fatal outcome before day 30. In non-ICU patients, older age, hemato-oncologic malignancies, chronic liver disease, and COVID-19 were all independently associated with mortality risk, while treatment consultation by an infectious disease or clinical microbiology consultant, and initial treatment with an echinocandin, respectively, higher EQUAL Candida scores were associated with lower mortality risk in the multivariable Cox regression models. In conclusion, despite higher comorbidity rates, non-ICU patients with candidemia had higher survival rates.